Form 4 · Filed Jul 2, 2026, 12:08 AM UTC
RGNX/REGENXBIO Inc.
PAKOLA STEVE — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | M | other | 36,725 | $8 | $288,659 | 249,734 |
| Jul 1, 2026 | S | sell | 36,725 | $13 | $472,284 | 213,009 |
| Jul 1, 2026 | M | other | 36,725 | — | — | 66,973 |
| Jun 29, 2026 | S | sell | 19,608 | $11 | $216,472 | 213,009 |
Source: SEC EDGAR raw filing ↗ · Accession 0001700659-26-000012